Identifying of Anticoagulant Ingredients From Moutan Cortex Based on Spectrum‐Effect Relationship Analysis Combined With GRA, PLS, and SVM Algorithms
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Weijie Pan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Guangdong Pharmaceutical University/Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica, S…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Anticoagulants, Paeonia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Moutan Cortex (MC) is a renowned Chinese medicine used for promoting blood circulation and removing blood stasis. However, the active ingredients are unclear. This study aimed to identify and validate the active ingredients of MC. UPLC fingerprints of 23 batches of MC from various origins were analyzed. The activating blood efficacy of MC was assessed by evaluating the inhibitory effects on thrombin and factor Xa (FXa) using the chromogenic substrate method. Active ingredients were identified through spectrum‐effect relationship analysis using gray relation analysis (GRA), partial least squares (PLS), and support vector machine (SVM) algorithms. Consequently, five components were identified as potential active ingredients: mudanpioside H, oxypaeoniflorin, 1,2,3,4,6‐penta‐O‐galloyl‐β‐d‐glucose (PGG), benzoyloxypaeoniflorin, and suffruticoside A/B/C/D. The pharmacological activities of these five active ingredients were further confirmed by measuring their thrombin inhibition ability and antithrombotic effects in zebrafish, and their interactions with thrombin and FXa were examined using molecular docking technology. Oxypaeoniflorin, benzoyloxypaeoniflorin, and PGG demonstrated significant efficacy in promoting blood circulation and resolving blood stasis, as well as strong binding affinities. This study provides a biochemical foundation for the anticoagulant effects of MC and offers valuable insights for quality control and the development of novel anticoagulant ingredients drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University/Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica, State Administration of Traditional Chinese Medicine (TCM)/Engineering…
- College of Pharmacy, Jinan University, Guangzhou, China.
- Medical Research Center, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Jinan University, Guangzhou, China.
- Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzh…
ORCID-Profile: Jiang Meng
Förderung
- National Natural Science Foundation of China
- Guangzhou Science and Technology Plan Project
Zitieren
APA
Pan, W., Chen, Q., Wu, M., Sun, Y., Li, M., Wang, S., Xue, X., & Meng, J. (2025). Identifying of Anticoagulant Ingredients From Moutan Cortex Based on Spectrum‐Effect Relationship Analysis Combined With GRA, PLS, and SVM Algorithms. Biomedical Chromatography. https://doi.org/10.1002/bmc.70060
Vancouver
Pan W, Chen Q, Wu M, Sun Y, Li M, Wang S, et al. Identifying of Anticoagulant Ingredients From Moutan Cortex Based on Spectrum‐Effect Relationship Analysis Combined With GRA, PLS, and SVM Algorithms. Biomedical Chromatography. 2025. doi:10.1002/bmc.70060
BibTeX
@article{Pan2025,
author = {Pan, Weijie and Chen, Qianru and Wu, Menghua and Sun, Yue and Li, Ming and Wang, Shumei and Xue, Xingyang and Meng, Jiang},
title = {Identifying of Anticoagulant Ingredients From Moutan Cortex Based on Spectrum‐Effect Relationship Analysis Combined With GRA, PLS, and SVM Algorithms},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70060}
}
EUVIMED